The start-up meeting is for companies we have not previously worked with. We invite all other companies to a dialogue meeting after the treatment protocol has been approved by the Medicines Council.
A dialogue meeting between Amgros and the supplier takes place after the Medicines Council has approved the protocol. The objective is to plan an appropriate process. At dialogue meetings, we discuss the health economics aspects and align expectations for the deliverables and timetable up to the decision by the Medicines Council.
It is important for Amgros that we have a good dialogue with the applicant during the process. This ensures the best possible conditions for applications to comply with the framework set for the timeline, methods and quality. The need for dialogue will vary from case to case. However, we encourage applicants to contact us if they are in doubt about the process, or if there are any changes underway.
Is there is a reasonable relationship between the added clinical value from a new pharmaceutical compared with the existing treatment, and the costs this entails?READ MORE
Negotiation of prices
When the Danish Medicines Council has determined the added clinical value of a new pharmaceutical, Amgros will negotiate with the applicantREAD MORE
I’m responsible for operation and development of business intelligence and health economics. I make sure that our department can proudly claim to be the partner who gets things done.
Lasse Lund Gundtoft
I work as a negotiator for new pharmaceuticals and I coordinate Amgros' activities in relation to the Danish Medicines Council.